Daniel J. Moore
Works at
Vanderbilt University Medical Center
Associate professor
Sources: reporter.nih.gov
Grants and prizes
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes, R01DK137997, 2024–2027, 10 Aug 2026
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Optimizing Stage 2 T1DM Management: Assessing the Impact of GLP-1Ra on Metabolic Outcomes in Patients Receiving Teplizumab, R01DK139322, 2024–2027, 26 Mar 2026
Sources: reporter.nih.gov